The estimated Net Worth of Kathleen Bardwell is at least 6.1 百万$ dollars as of 28 June 2019. Kathleen Bardwell owns over 7,000 units of Steris Plc stock worth over 5,913,042$ and over the last 9 years Kathleen sold STE stock worth over 184,330$.
Kathleen has made over 11 trades of the Steris Plc stock since 2015, according to the Form 4 filled with the SEC. Most recently Kathleen exercised 7,000 units of STE stock worth 374,640$ on 28 June 2019.
The largest trade Kathleen's ever made was exercising 7,000 units of Steris Plc stock on 28 June 2019 worth over 374,640$. On average, Kathleen trades about 803 units every 36 days since 2015. As of 28 June 2019 Kathleen still owns at least 24,428 units of Steris Plc stock.
You can see the complete history of Kathleen Bardwell stock trades at the bottom of the page.
Kathleen's mailing address filed with the SEC is C/O VAREX IMAGING CORP., 1678 S. PIONEER ROAD, SALT LAKE CITY, UT, 84104.
Over the last 9 years, insiders at Steris Plc have traded over 157,726,045$ worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves、Walter M Jr Rosebrough、John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of 3,374,074$. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth 113,369$.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: